Health-related quality of life and drug treatment satisfaction were low and correlated negatively with symptoms in patients having severe refractory chronic rhinosinusitis with nasal polyps

Allergol Int. 2021 Jul;70(3):370-372. doi: 10.1016/j.alit.2020.11.010. Epub 2020 Dec 25.

Authors

Mitsuhiro Okano¹, Kenji Kondo², Makiko Takeuchi³, Yurie Taguchi³, Hiroyuki Fujita⁴

Affiliations

¹ Department of Otorhinolaryngology, Graduate School of Medicine, International University of Health and Welfare, Chiba, Japan.
² Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
³ Sanofi K.K., Tokyo, Japan.
⁴ Sanofi K.K., Tokyo, Japan. Electronic address: [email protected].

PMID: 33358385
DOI: 10.1016/j.alit.2020.11.010

No abstract available

Publication types

Letter

MeSH terms

Anti-Allergic Agents / therapeutic use
Chronic Disease
Humans
Nasal Polyps / complications*
Nasal Polyps / diagnosis
Nasal Polyps / drug therapy
Nasal Polyps / epidemiology*
Patient Satisfaction*
Quality of Life*
Recurrence
Rhinitis / complications*
Rhinitis / diagnosis
Rhinitis / drug therapy
Rhinitis / epidemiology*
Severity of Illness Index
Sinusitis / complications*
Sinusitis / diagnosis
Sinusitis / drug therapy
Sinusitis / epidemiology*
Treatment Outcome

Substances

Anti-Allergic Agents